Check-Cap Ltd. (NASDAQ:CHEK – Get Free Report) shares crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.99 and traded as high as $1.96. Check-Cap shares last traded at $1.82, with a volume of 202,527 shares traded.
Analyst Ratings Changes
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Check-Cap in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.
Check Out Our Latest Stock Report on Check-Cap
Check-Cap Price Performance
Check-Cap Company Profile
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
See Also
- Five stocks we like better than Check-Cap
- How to Use the MarketBeat Dividend Calculator
- This AI Chip Giant Could Be the Market’s Next Big Winner
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- Transportation Stocks Investing
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.